Citeline’s Brian Yang and Dexter Yan discuss recent China biotech hot topics incl. antibody drug conjugate deals, China’s planning to ban gene editing export, volume-based procurement in 2023 and China biotech’s paradox and outlooks in the new year of rabbit.

https://scrip.pharmaintelligence.informa.com/SC147973/Chinese-Language-Podcast--ADC